← Back
$ACRV All transactions

Acrivon Therapeutics, Inc.

F

$ Value

$68K

Shares

59,766

Price

$1

Filed

May 16

Insider

Name

Blume-Jensen Peter

Title

President and CEO

CIK

0001950499

Roles

Director Officer

Transaction Details

Transaction Date

2025-05-14

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

2,226,015

Footnotes

Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. | These securities are held by President and CEO, Dr. Peter Blume-Jensen, who is also Dr. Kristina Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein. | These securities are held by co-founder and EVP, Dr. Kristina Masson, who is also Dr. Blume-Jensen's spouse. Dr. Blume-Jensen disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Filing Info

Accession No.

0000905148-25-001820

Form Type

4

Issuer CIK

0001781174

Blume-Jensen Peter's History

Date Ticker Type Value
2025-08-21 ACRV F $26K
2025-08-14 ACRV F $83K
2025-08-14 ACRV F $681
2025-05-21 ACRV F $23K
2025-05-14 ACRV F $68K
2025-05-14 ACRV F $560

Other Insiders at ACRV (90d)

Insider Bought Sold Last
RA CAPITAL MANAGEMENT, L.P. 2026-04-22
Miller Mary
Chief Legal Officer
2026-04-17